User profiles for Thaddeus Wadas

Thad J Wadas

Associate Professor of Radiology, University of Iowa
Verified email at uiowa.edu
Cited by 4067

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

TJ Wadas, EH Wong, GR Weisman… - Chemical …, 2010 - ACS Publications
Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems. Molecular …

Vapochromism and its structural basis in a luminescent Pt (II) terpyridine− nicotinamide complex

TJ Wadas, QM Wang, Y Kim… - Journal of the …, 2004 - ACS Publications
A novel Pt(II) terpyridine complex that has a nicotinamide moiety linked to the terpyridyl ligand
has been synthesized in good yield and studied structurally and spectroscopically. The …

Platinum chromophore-based systems for photoinduced charge separation: a molecular design approach for artificial photosynthesis

S Chakraborty, TJ Wadas, H Hester… - Inorganic …, 2005 - ACS Publications
Photoinduced charge separation is a fundamental step in photochemical energy conversion.
In the design of molecularly based systems for light-to-chemical energy conversion, this …

[HTML][HTML] Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development

…, BM Ehrmann, M Wright, U Bierbach, TJ Wadas - Chemical …, 2017 - pubs.rsc.org
We report our initial investigations into the use of tetraazamacrocycles as zirconium-89
chelators. We describe the synthesis and complete characterization of several Zr …

[HTML][HTML] Recent advances in zirconium-89 chelator development

NB Bhatt, DN Pandya, TJ Wadas - Molecules, 2018 - mdpi.com
The interest in zirconium-89 ( 89 Zr) as a positron-emitting radionuclide has grown considerably
over the last decade due to its standardized production, long half-life of 78.2 h, favorable …

[HTML][HTML] Development of targeted alpha particle therapy for solid tumors

…, NI Khushalani, EG Moros, ML McLaughlin, TJ Wadas… - Molecules, 2019 - mdpi.com
Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-particles
(cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or small …

64Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity

L Wei, Y Ye, TJ Wadas, JS Lewis, MJ Welch… - Nuclear medicine and …, 2009 - Elsevier
OBJECTIVES: The α v β 3 integrin is a cell adhesion molecule known to be involved in stages
of angiogenesis and metastasis. In this study, the chelators CB-TE2A and diamsar were …

[HTML][HTML] Preliminary therapy evaluation of 225Ac-DOTA-c (RGDyK) demonstrates that Cerenkov radiation derived from 225Ac daughter decay can be detected by …

…, DL Morse, I Batista, A Mintz, KC Li, TJ Wadas - Theranostics, 2016 - ncbi.nlm.nih.gov
The theranostic potential of 225 Ac-based radiopharmaceuticals continues to increase as
researchers seek innovative ways to harness the nuclear decay of this radioisotope for …

Radiolabeling of TETA-and CB-TE2A-conjugated peptides with copper-64

TJ Wadas, CJ Anderson - Nature protocols, 2006 - nature.com
The number of radiopharmaceuticals containing copper radionuclides for diagnostic
imaging and targeted radiotherapy has grown considerably over the past few decades. This …

Molecular targeted α-particle therapy for oncologic applications

TJ Wadas, DN Pandya… - American Journal of …, 2014 - Am Roentgen Ray Soc
OBJECTIVE. A significant challenge facing traditional cancer therapies is their propensity to
significantly harm normal tissue. The recent clinical success of targeting therapies by …